Hereditary tyrosinemia type 1 in children

Hereditary tyrosinemia type 1 in children

Hereditary metabolic disorders include a group of diseases (more than 400) when a defect of a particular gene changes the metabolic process leading either to the accumulation of unwanted metabolites, or to a deficiency of a substance. This group also includes hereditary tyrosinemia type 1, a severe...

Full description

Bibliographic Details
Main Authors:	G. V. Volynets, A. V. Nikitin, T. A. Skvortsova
Format:	Article
Language:	Russian
Published:	Ltd. “The National Academy of Pediatric Science and Innovation” 2019-11-01
Series:	Rossijskij Vestnik Perinatologii i Pediatrii
Subjects:	children hereditary tyrosinemia diagnostics treatment clinical observations
Online Access:	https://www.ped-perinatology.ru/jour/article/view/972

Similar Items

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
by: Imad Dweikat, et al.
Published: (2021-03-01)

Hereditary Tyrosinemia Type 1—A Rare Disease with Typical Radiological Features: Case Report and Review of Literature
by: Somesh Singh, et al.
Published: (2020-05-01)

The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening
by: Jessica R. C. Priestley, et al.
Published: (2020-05-01)

First Macedonian child with tyrosinemia type 1 successfully treated with nitisinone and report of a novel mutation in the FAH gene
by: Kostovski Aco, et al.
Published: (2017-01-01)

Neonatal hyperinsulinism in transient and classical forms of tyrosinemia
by: Swathi Sethuram, et al.
Published: (2021-04-01)

Peripheral Neuropathy and Hereditary Tyrosinemia
by: J Gordon Millichap
Published: (1990-03-01)

Generation of an induced pluripotent stem cell line SDQLCHi026-A from a hereditary tyrosinemia type I patient carrying compound heterozygote mutations in FAH gene
by: Haiyan Zhang, et al.
Published: (2021-05-01)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
by: Das AM
Published: (2017-07-01)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
by: Jon Gil-Martínez, et al.
Published: (2021-02-01)

The molecular basis of the genetic mosaicism in hereditary tyrosinemia (HT1) / Etresia van Dyk
by: Van Dyk, Etresia
Published: (2013)

The molecular basis of the genetic mosaicism in hereditary tyrosinemia (HT1) / Etresia van Dyk
by: Van Dyk, Etresia
Published: (2013)

Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
by: Haaike Colemonts-Vroninks, et al.
Published: (2021-12-01)

Diagnostic and Therapeutic Challenges of Hereditary Tyrosinemia Type 1 in Lebanon: A 12-Year Retrospective Review
by: Karim N. Daou, et al.
Published: (2021-08-01)

Treatment adherence in tyrosinemia type 1 patients
by: Domingo González-Lamuño, et al.
Published: (2021-06-01)

Type 1 Tyrosinemia with Hypophosphatemic Rickets; a Case Report
by: Peyman Eshraghi, et al.
Published: (2014-09-01)

Type 1 tyrosinemia in Finland: a nationwide study
by: Linnea Äärelä, et al.
Published: (2020-10-01)

Autism Symptoms Related to Tyrosinemia Type III: A Case Report
by: Ayşegül Yolga Tahiroğlu, et al.
Published: (2008-08-01)

Tyrosinemia type III in an asymptomatic girl
by: Edyta Szymanska, et al.
Published: (2015-12-01)

A Case Report of a Very Rare Association of Tyrosinemia type I and Pancreatitis Mimicking Neurologic Crisis of Tyrosinemia Type I
by: Habibe Koç Uçar, et al.
Published: (2016-06-01)

Clinical Features of 29 Patients with Hereditary Tyrosinemia I in Western Turkey
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Richner-Hanhart Syndrome (Tyrosinemia Type II) A Case Report of Delay Diagnosis with Hyperkeratotic Lesions of Palmes and Soles
by: Zahra Alian
Published: (2014-12-01)

Clinical and para clinical findings in the children with tyrosinemia referring for liver transplantation
by: Seyed Mohsen Dehghani, et al.
Published: (2013-01-01)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
by: Willem G. van Ginkel, et al.
Published: (2019-11-01)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
by: Fábio Barroso, et al.

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
by: Reza Najafi, et al.
Published: (2018-01-01)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
by: Anne Daly, et al.
Published: (2021-09-01)

Tyrosinemia Type I and Reversible Neurogenic Crisis After a One-Month Interruption of Nitisinone
by: Havva Yazıcı, et al.
Published: (2018-03-01)

Evaluation of pre-symptomatic nitisinone treatment on long-term outcomes in Tyrosinemia type 1 patients: a systematic review
by: Julia Geppert, et al.
Published: (2017-09-01)

Heat Shock Response Associated with Hepatocarcinogenesis in a Murine Model of Hereditary Tyrosinemia Type I
by: Francesca Angileri, et al.
Published: (2014-04-01)

Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet
by: María Ignacia García, et al.
Published: (2017-06-01)

Design of Polymerase Chain Reaction Initiators and Their Function to Identify FAH Mutations in Type I Tyrosinemia
by: A Keshtkari, et al.
Published: (2019-11-01)

The structure of hereditary diseases in children hospitalized in a specialized clinic
by: E. A. Nikolaeva, et al.
Published: (2019-11-01)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
by: Kimber van Vliet, et al.
Published: (2019-08-01)

Cirrose hepática e hemocromatose neonatal secundária associadas à tirosinemia tipo 1: relato de um caso e diagnóstico diferencial com hemocromatose primária hereditária Liver cirrhosis and secondary neonatal haemochromatosis associated to type 1 tyrosinemia: case report and differential diagnosis with hereditary haemochromatosis
by: Ana Paula Camargo Martins, et al.
Published: (2006-04-01)

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients
by: Kimber van Vliet, et al.
Published: (2019-12-01)

Blood and Brain Biochemistry and Behaviour in NTBC and Dietary Treated Tyrosinemia Type 1 Mice
by: Willem G. van Ginkel, et al.
Published: (2019-10-01)

HEREDITARY, VARIABILITY AND PATHOLOGY. PART 2
by: P. F. Litvitskii
Published: (2012-09-01)

CATAMNESIS OF CHILDREN WITH COMPROMISED HEREDITARY BACKGROUND OF THROMBOSIS
by: L. V. Zhdanova, et al.
Published: (2014-04-01)

Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I
by: Peng Gu, et al.
Published: (2021-06-01)

Tyrosinemia type I as a model for studying epigenetic events in the aetiology of metabolic disease associated hepatocarcinoma / Gouws, C.
by: Gouws, Chrisna
Published: (2012)